Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome

NCT00454688 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

596

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: Asimadoline
DRUG: Placebo

Sponsor

Tioga Pharmaceuticals

Collaborators

[object Object]